Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review
Open Access
- 2 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1579924
Abstract
Background: CD38, a glycoprotein with a single transmembrane structure, is extensively found in erythrocytes, immune cells, and endothelial cells. Primarily located on cell membranes, it plays a critical role in metabolizing nicotinamide adenine dinucleotide (NAD), thereby maintaining NAD homeostasis in vivo. As a vital coenzyme, NAD is involved in numerous biological processes, including energy metabolism, apoptosis, and DNA repair. CD38, as a major NAD-depleting enzyme, is pivotal in regulating intracellular NAD levels and various physiological processes. Given its significance, understanding the function of CD38 and its implications in aging and age-related diseases is crucial for elucidating disease pathogenesis and developing therapeutic strategies.Methods: This study conducted a bibliometric analysis to explore recent research trends and advancements in the field of CD38. Research articles were retrieved from the Web of Science database, followed by a bibliometric assessment using CiteSpace and VOSviewer to visualize key publication trends, contributions by countries and institutions, and keyword distributions. Based on the bibliometric analysis, key insights were synthesized to elucidate the role of CD38 in aging and age-related diseases, its underlying mechanisms, and its applications in clinical evaluation, detection methods, interventions, and therapeutic targets.Results: The bibliometric analysis revealed an exponential increase in the number of published articles over time, with the United States and China emerging as the leading research hubs. The predominant keywords included ‘CD38’ and ‘blood-related disorders’. Furthermore, key findings highlighted the critical role of CD38 in aging and age-related diseases, emphasizing its mechanisms in NAD metabolism and its potential as a therapeutic target. Moreover, current applications of CD38 in clinical evaluation and detection methods were discussed, showcasing its growing importance in biomedical research.Conclusion: This study underscores the growing interest in CD38 research, particularly its role in aging and age-related diseases. The findings highlight the significance of CD38 in maintaining NAD homeostasis and its potential as a therapeutic target. The exponential growth in publications and the dominance of the United States and China in this field reflect the global importance of CD38 research. Future studies should further explore the mechanistic insights and clinical applications of CD38 to advance therapeutic strategies for age-related diseases.Keywords
This publication has 74 references indexed in Scilit:
- Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myelomaHemaSphere, 2024
- CD38 deficient mice are not protected from atherosclerosisBiochemical and Biophysical Research Communications, 2024
- Hallmarks of aging: An expanding universeCell, 2023
- NAD+ flux is maintained in aged mice despite lower tissue concentrationsCell Systems, 2021
- The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ declineBiochemical and Biophysical Research Communications, 2019
- Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 DeacetylationCell Reports, 2017
- The multi-faceted potential of CD38 antibody targeting in multiple myelomaCancer Immunology, Immunotherapy, 2017
- CD38 Knockout Mice Show Significant Protection Against Ischemic Brain Damage Despite High Level Poly-ADP-RibosylationNeurochemical Research, 2016
- Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancerTumor Biology, 2014
- CD38 in Bovine Lung: A Multicatalytic NADaseThe Journal of Membrane Biology, 2009